It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

This site is intended for patients in the UK who have been prescribed Entresto® (sacubitril/valsartan). This website has been developed and funded by Novartis Pharmaceuticals UK Ltd. If you are a member of the public, please click here

Do not stop taking your medicine unless your healthcare professional tells you to

Stopping your treatment with Entresto may cause your condition to get worse. If you have any further questions on the use of this medicine, ask your doctor or pharmacist1

Watch how Entresto® (sacubitril/valsartan) works

This mode of action video demonstrates sacubitril/valsartan’s impact on your heart failure. Watch now to learn more about the effects.

Treating symptomatic adults with chronic heart failure and reduced ejection fraction with sacubitril/valsartan

Interact with this tool to see the impact of heart failure on the overall health of the heart.

button

UK | June 2024 | 197476-1

YOURCHOICE
ENGAGE

laptop icon

Supporting you at every stage of your treatment journey

The Entresto® YOURCHOICE ENGAGE programme provides patients like you with valuable support on your treatment journey. Through regular emails we can support you in learning more about your Entresto® treatment, understand how to manage any possible side effects and even help you to find further helpful information and resources.

YOURCHOICE ENGAGE can also help you to:

  • Find reliable and up-to-date information relevant to you

  • Read and hear stories from other patients

  • Learn tips to help you stay on track with your treatment

  • Discover information and sources of emotional and well-being support

LEARN MORE

References

  1. EMC. Entresto patient information leaflet. Available online at: https://www.medicines.org.uk/emc/files/pil.7751.pdf [Last accessed: July 2024]

UK | July 2024 | 172746-3

Reporting of side effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack. You can report side effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of your medication.

Novartis Pharmaceuticals UK Limited is a limited liability company registered in England and Wales under number 119006. Registered office: The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ.

Use of this website is governed by our terms of use and privacy policy. Click here to review and change your . Accessibility. cookie settings

UK | July 2024 | 262485-1

My Entresto

© 2024 Novartis Pharmaceuticals UK Ltd. All rights reserved.
This site is intended for patients in the UK who have been prescribed Entresto.

Novartis